WHO issues guidance against pharmacological and surgical treatment for childhood obesity

The WHO released guidance advising against pharmacological treatment, bariatric surgery, and weight-loss devices for children with obesity, recommending lifestyle interventions instead. The guidance is a policy statement, not a new clinical trial result, and its impact on national health policies remains to be seen. This matters as childhood obesity rates rise globally, and the guidance could shape public health approaches.